Minimal within-host dengue models highlight the specific roles of the immune response in primary and secondary dengue infections
暂无分享,去创建一个
[1] Alan S. Perelson,et al. Modeling Within-Host Dynamics of Influenza Virus Infection Including Immune Responses , 2012, PLoS Comput. Biol..
[2] Nuning Nuraini,et al. A with-in host Dengue infection model with immune response , 2009, Math. Comput. Model..
[3] Michael A. Johansson,et al. The Incubation Periods of Dengue Viruses , 2012, PloS one.
[4] Simon Wain-Hobson. Virus Dynamics: Mathematical Principles of Immunology and Virology , 2001, Nature Medicine.
[5] A. Rothman,et al. Immunopathogenesis versus Protection in Dengue Virus Infections , 2014, Current Tropical Medicine Reports.
[6] A. Mustafa,et al. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. , 2000, FEMS immunology and medical microbiology.
[7] Anita Chakravarti,et al. Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak. , 2006, The Indian journal of medical research.
[8] A. Dobson,et al. Linking Influenza Virus Tissue Tropism to Population-Level Reproductive Fitness , 2012, PloS one.
[9] A. Sabin. Research on dengue during World War II. , 1952, The American journal of tropical medicine and hygiene.
[10] A. Nisalak,et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. , 2002, The Journal of infectious diseases.
[11] A. Rothman,et al. Understanding the contribution of cellular immunity to dengue disease pathogenesis , 2008, Immunological reviews.
[12] Alan S. Perelson,et al. Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..
[13] D. Hober,et al. High Levels of sTNFR p75 and TNFα in Dengue‐Infected Patients , 1996 .
[14] Pejman Rohani,et al. Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity , 2013, Journal of The Royal Society Interface.
[15] A. Rothman. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms , 2011, Nature Reviews Immunology.
[16] A. Perelson. Modelling viral and immune system dynamics , 2002, Nature Reviews Immunology.
[17] J. Farrar,et al. Timing of CD8+ T Cell Responses in Relation to Commencement of Capillary Leakage in Children with Dengue , 2010, The Journal of Immunology.
[18] Andreas Handel,et al. Towards a quantitative understanding of the within-host dynamics of influenza A infections , 2010, Journal of The Royal Society Interface.
[19] Ravi V. Kolla,et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells , 2013, Proceedings of the National Academy of Sciences.
[20] Matthew D. H. Lay,et al. Killer T cells regulate antigen presentation for early expansion of memory, but not naive, CD8+ T cell , 2007, Proceedings of the National Academy of Sciences.
[21] A. Basu,et al. Vascular endothelium: the battlefield of dengue viruses , 2008, FEMS immunology and medical microbiology.
[22] Sophie Yacoub,et al. The pathogenesis of dengue , 2013, Current opinion in infectious diseases.
[23] Tanvi P. Gujarati,et al. Virus antibody dynamics in primary and secondary dengue infections , 2012, Journal of Mathematical Biology.
[24] Ann Cullinane,et al. Dynamics of Influenza Virus Infection and Pathology , 2010, Journal of Virology.
[25] E. Harris,et al. Innate immunity to dengue virus infection and subversion of antiviral responses. , 2014, Journal of molecular biology.
[26] S. Halstead,et al. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection , 2013, Archives of Virology.
[27] H. Ansari,et al. A With-In Host Dengue Infection Model with Immune Response and Beddington-DeAngelis Incidence Rate , 2012 .
[28] Yun-Chi Chen,et al. Activation of Terminally Differentiated Human Monocytes/Macrophages by Dengue Virus: Productive Infection, Hierarchical Production of Innate Cytokines and Chemokines, and the Synergistic Effect of Lipopolysaccharide , 2002, Journal of Virology.
[29] S. Sekaran,et al. Cytokine Expression Profile of Dengue Patients at Different Phases of Illness , 2012, PloS one.
[30] Laetitia Canini,et al. Population Modeling of Influenza A/H1N1 Virus Kinetics and Symptom Dynamics , 2010, Journal of Virology.
[31] Alan S. Perelson,et al. Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy , 1998 .
[32] Suresh Mahalingam,et al. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes , 2010, The Lancet Infectious Diseases.
[33] M. Fernandez-Garcia,et al. Pathogenesis of flavivirus infections: using and abusing the host cell. , 2009, Cell host & microbe.
[34] D. Kirschner,et al. A methodology for performing global uncertainty and sensitivity analysis in systems biology. , 2008, Journal of theoretical biology.
[35] W. Yokoyama,et al. The dynamic life of natural killer cells. , 2004, Annual review of immunology.
[36] C. Thepparit,et al. Behavior of the dengue virus in solution , 2003, Journal of medical virology.
[37] A. Nisalak,et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.
[38] A. Nisalak,et al. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. , 1999, The Journal of infectious diseases.
[39] Susana Vázquez,et al. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. , 2002, Revista panamericana de salud publica = Pan American journal of public health.
[40] S. Yoksan,et al. Alteration of Cytokines and Chemokines During Febrile Episodes Associated With Endothelial Cell Damage and Plasma Leakage in Dengue Hemorrhagic Fever , 2012, The Pediatric infectious disease journal.
[41] Cameron P. Simmons,et al. Kinetics of Viremia and NS1 Antigenemia Are Shaped by Immune Status and Virus Serotype in Adults with Dengue , 2011, PLoS neglected tropical diseases.
[42] Gideon Schreiber,et al. Prolonging the half-life of human interferon-α2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-α2 , 2001 .
[43] A. Nisalak,et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. , 1991, The Journal of clinical investigation.
[44] E. Harris,et al. Early Clinical Features of Dengue Virus Infection in Nicaraguan Children: A Longitudinal Analysis , 2012, PLoS neglected tropical diseases.
[45] S. Halstead,et al. Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. , 1990, The Journal of general virology.
[46] Bjoern Peters,et al. Immunodominance Changes as a Function of the Infecting Dengue Virus Serotype and Primary versus Secondary Infection , 2014, Journal of Virology.
[47] Alan L Rothman,et al. Dengue: defining protective versus pathologic immunity. , 2004, The Journal of clinical investigation.
[48] C. King,et al. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] A. Nisalak,et al. Cross-Reactivity and Expansion of Dengue-Specific T cells During Acute Primary and Secondary Infections in Humans , 2011, Scientific reports.
[50] J. Farrar,et al. Kinetics of Plasma Viremia and Soluble Nonstructural Protein 1 Concentrations in Dengue: Differential Effects According to Serotype and Immune Status , 2011, The Journal of infectious diseases.
[51] A. Nisalak,et al. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. , 1989, The American journal of tropical medicine and hygiene.
[52] D. Hober,et al. High levels of sTNFR p75 and TNF alpha in dengue-infected patients. , 1996, Microbiology and immunology.
[53] Xiaoping Tang,et al. Both Viremia and Cytokine Levels Associate with the Lack of Severe Disease in Secondary Dengue 1 Infection among Adult Chinese Patients , 2010, PloS one.
[54] S. Kapoor,et al. Elevated levels of IL‐8 in dengue hemorrhagic fever , 1998, Journal of medical virology.
[55] D. Hober,et al. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. , 1993, The American journal of tropical medicine and hygiene.
[56] Marta Ospina,et al. Serum levels of interleukin-6, tumor necrosis factor-alpha and interferon-gamma in infants with and without dengue. , 2008, Revista da Sociedade Brasileira de Medicina Tropical.
[57] A. Perelson,et al. Kinetics of Influenza A Virus Infection in Humans , 2006, Journal of Virology.
[58] G. Schreiber,et al. Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-alpha 2. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[59] Tao Dong,et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever , 2003, Nature Medicine.
[60] John S. Brownstein,et al. The global distribution and burden of dengue , 2013, Nature.
[61] E. Azeredo,et al. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease , 2006, Clinical and experimental immunology.
[62] P. Desprès,et al. Innate immune responses to dengue virus. , 2005, Archives of medical research.
[63] E L Braga,et al. Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. , 2001, Memorias do Instituto Oswaldo Cruz.
[64] Hana M. Dobrovolny,et al. Assessing Mathematical Models of Influenza Infections Using Features of the Immune Response , 2013, PloS one.
[65] Alan L Rothman,et al. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. , 2004, The Journal of infectious diseases.
[66] Albert D. M. E. Osterhaus,et al. Dengue Virus Pathogenesis: an Integrated View , 2009, Clinical Microbiology Reviews.
[67] D. Tough,et al. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection , 2007, Immunology.
[68] S. Green,et al. Markers of dengue disease severity. , 2010, Current topics in microbiology and immunology.
[69] J. Rajapakse,et al. Serum Proteome and Cytokine Analysis in a Longitudinal Cohort of Adults with Primary Dengue Infection Reveals Predictive Markers of DHF , 2012, PLoS neglected tropical diseases.
[70] D. Hober,et al. Serum Levels of Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6), and Interleukin-1β (IL-1β) in Dengue-Infected Patients , 1993 .
[71] Hadi Dowlatabadi,et al. Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission: an HIV Model, as an Example , 1994 .
[72] Michael G. Katze,et al. Into the Eye of the Cytokine Storm , 2012, Microbiology and Molecular Reviews.
[73] Eduardo Hage Carmo,et al. Influência do aumento do acesso à atenção básica no comportamento da taxa de detecção de hanseníase de 1980 a 2006 , 2008 .
[74] Edward C. Holmes,et al. Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes , 2013, Proceedings of the National Academy of Sciences.
[75] S. Lada,et al. Gamma Interferon (IFN-γ) Receptor Restricts Systemic Dengue Virus Replication and Prevents Paralysis in IFN-α/β Receptor-Deficient Mice , 2012, Journal of Virology.
[76] N. Wauquier,et al. Control of Acute Dengue Virus Infection by Natural Killer Cells , 2014, Front. Immunol..
[77] Cameron P. Simmons,et al. Within-host viral dynamics of dengue serotype 1 infection , 2014, Journal of The Royal Society Interface.
[78] M. Guzmán,et al. Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever. , 2010, Human immunology.
[79] A S Perelson,et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. , 1998, Science.
[80] B. Murphy,et al. Immune response to dengue virus and prospects for a vaccine. , 2011, Annual review of immunology.
[81] Eva Harris,et al. Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical , 2004, Journal of Virology.
[82] M. Sinniah,et al. Augmented inflammatory cytokines in primary dengue infection progressing to shock. , 1995, Singapore medical journal.